Characteristic Overall
N = 231
1
Amyloid cardiomyopathy
N = 119
1
Hypertensive organ damage (no CMP)
N = 30
1
Hypertrophic cardiomyopathy
N = 82
1
p-value2
Systolic.Blood.Pressure..mmHg. 130 (110, 144) 120 (110, 140) 140 (125, 160) 130 (115, 148) <0.001
Diastolic.Blood.Pressure..mmHg. 70 (65, 80) 70 (65, 80) 80 (73, 90) 75 (70, 85) <0.001
NYHA.Class



<0.001
    Class I 106 (48%) 32 (28%) 19 (66%) 55 (71%)
    Class II 66 (30%) 43 (38%) 7 (24%) 16 (21%)
    Class III 45 (20%) 36 (32%) 3 (10%) 6 (7.8%)
    Class IV 3 (1.4%) 3 (2.6%) 0 (0%) 0 (0%)
Heart.Rate..bpm. 70 (60, 82) 75 (63, 85) 67 (61, 75) 66 (59, 80) 0.008
PR.Interval..ms. 180 (160, 210) 200 (160, 226) 172 (150, 200) 166 (146, 190) 0.001
QRS.Duration..ms. 100 (80, 120) 100 (80, 130) 95 (90, 128) 90 (80, 120) 0.7
QTc.Interval..ms. 439 (410, 463) 447 (416, 468) 421 (383, 447) 433 (402, 454) 0.025
Q.Waves 19 (8.2%) 8 (6.7%) 2 (6.7%) 9 (11%) 0.6
ST.Segment.Abnormalities 12 (5.2%) 6 (5.0%) 1 (3.4%) 5 (6.1%) >0.9
Left.Ventricular.Hypertrophy 34 (15%) 4 (3.4%) 1 (3.3%) 29 (35%) <0.001
Right.Ventricular.Hypertrophy




    No 231 (100%) 119 (100%) 30 (100%) 82 (100%)
Low.QRS.Voltage 29 (14%) 24 (22%) 2 (7.4%) 3 (4.4%) 0.002
Hemoglobin..g.l. 13.35 (11.90, 14.70) 12.65 (11.10, 14.00) 13.70 (12.50, 14.30) 14.55 (12.80, 15.20) <0.001
Creatinine..mg.dl. 1.10 (0.94, 1.40) 1.23 (1.00, 1.56) 1.31 (0.99, 1.60) 0.99 (0.85, 1.16) <0.001
eGFR..ml.min.1.73m2. 75 (53, 90) 63 (47, 86) 62 (49, 81) 85 (73, 106) <0.001
K...mEq.l. 4.30 (4.00, 4.70) 4.40 (4.00, 4.70) 4.20 (4.00, 4.80) 4.30 (3.90, 4.70) 0.7
Troponin.I.high.sensitivity..ng.l. 58 (28, 143) 79 (45, 151) 38 (19, 38) 35 (17, 232) 0.3
BNP..ng.l. 437 (223, 656) 486 (274, 756) 223 (189, 256) 77 (60, 521) 0.11
NT.pro.BNP..ng.l. 1,909 (694, 3,863) 2,357 (1,532, 4,804) 664 (84, 1,650) 693 (458, 1,228) 0.001
IVS.Diastole..mm. 17.0 (15.0, 20.0) 18.0 (15.0, 20.0) 15.0 (13.0, 16.0) 18.0 (15.0, 20.0) <0.001
LV.Diameter.Diastole..mm. 45 (41, 48) 43 (39, 47) 46 (43, 51) 45 (41, 48) 0.035
LVPW.Diastole..mm. 13.0 (11.0, 15.0) 14.5 (12.0, 17.5) 11.0 (9.0, 12.0) 12.0 (10.0, 14.0) <0.001
iLVEDV..ml.m2. 47 (40, 55) 47 (40, 53) 52 (47, 64) 46 (39, 54) 0.033
iLVESV..ml.m2. 20 (16, 28) 23 (17, 27) 21 (16, 33) 17 (14, 26) 0.2
LVEF.... 58 (50, 65) 55 (45, 60) 60 (55, 65) 63 (59, 67) <0.001
iSV..ml.m2. 68 (60, 90) 65 (56, 72) 90 (67, 116) 74 (61, 99) 0.013
iLAV..ml.m2. 41 (31, 50) 43 (36, 53) 32 (28, 38) 39 (28, 50) <0.001
iRAV..ml.m2. 25 (18, 36) 33 (24, 44) 21 (19, 27) 21 (15, 29) <0.001
Mitral.E..m.s. 0.83 (0.64, 1.00) 0.99 (0.75, 1.00) 0.73 (0.61, 1.00) 0.64 (0.57, 1.00) 0.040
Lateral.Mitral.E...m.s. 0.06 (0.05, 0.08) 0.05 (0.04, 0.07) 0.08 (0.06, 0.09) 0.08 (0.06, 0.10) 0.001
Septal.Mitral.E...m.s. 0.050 (0.040, 0.060) 0.040 (0.035, 0.050) 0.068 (0.048, 0.080) 0.050 (0.050, 0.060) 0.012
Mitral.E.E..Ratio 14 (9, 18) 17 (14, 22) 10 (8, 13) 10 (8, 14) <0.001
LV.Outflow.Tract.Obstruction 27 (23%) 0 (0%) 1 (13%) 26 (35%) <0.001
LVOT.Basal.Gradient..mmHg. 37 (14, 75) NA (NA, NA) 75 (75, 75) 36 (14, 67) 0.3
LVOT.Dynamic.Gradient..mmHg. 67 (35, 88) NA (NA, NA) 75 (75, 75) 66 (31, 90) 0.6
TAPSE..mm. 20 (17, 24) 17 (16, 20) 21 (19, 23) 23 (20, 25) <0.001
S...m.s. 0.1 (0.1, 0.1) 0.1 (0.1, 0.1) 0.1 (0.1, 0.2) 0.1 (0.1, 0.1) 0.14
FAC.... 40 (32, 40) 38 (29, 40) NA (NA, NA) 44 (40, 51) 0.005
RV.Basal.Diameter..mm. 36 (33, 39) 37 (34, 40) 36 (33, 40) 35 (31, 38) 0.014
Tricuspid.Regurgitation.V.Max..m.s. 2.75 (2.50, 3.00) 2.80 (2.50, 3.06) 2.55 (2.55, 2.55) 2.23 (2.23, 2.23) 0.3
Inferior.Vena.Cava.Diameter..mm. 17 (15, 20) 18 (15, 22) 17 (15, 18) 17 (15, 18) 0.011
Inferior.Vena.Cava.Collapsibility.... 70 (60, 80) 70 (30, 80) 80 (70, 100) 70 (70, 80) <0.001
sPAP..mmHg. 33 (27, 40) 37 (30, 45) 30 (26, 35) 30 (25, 37) <0.001
LV.Global.Longitudinal.Strain.... -14.5 (-17.0, -12.0) -13.0 (-16.0, -10.0) -15.4 (-17.0, -13.8) -15.8 (-19.7, -13.3) 0.7
1 Median (Q1, Q3); n (%)
2 Kruskal-Wallis rank sum test; Fisher’s exact test